Trial Profile
Surveillance monitoring for ART [antiretroviral therapy] toxicities study in HIV uninfected children born to HIV infected women (SMARTT)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 01 Sep 2022
Price :
$35
*
At a glance
- Drugs Atazanavir (Primary) ; Tenofovir disoproxil fumarate (Primary) ; Antiretrovirals
- Indications HIV infections
- Focus Adverse reactions
- Acronyms SMARTT
- 23 Aug 2021 Planned End Date changed from 1 Jul 2021 to 1 Jul 2025.
- 23 Aug 2021 Planned primary completion date changed from 1 Jul 2021 to 1 Jul 2025.
- 23 Oct 2020 Planned End Date changed from 1 Jul 2020 to 1 Jul 2021.